Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P809: Disease severity in patients with inflammatory bowel disease associated with cardiovascular diseasesECCO '18 Vienna
Year: 2018
Authors:

A. Mantaka1*, E. Tsoukali2, M. Fragaki3, K. Karmiris3, N. Viazis2, G. Mantzaris2, I. Koutroubakis1

1University Hospital of Heraklion, Department of Gastroenterology, Heraklion, Greece, 2Evangelismos Hospital, Gastroenterology Unit, Athens, Greece, 3Venizeleion General Hospital, Department of Gastroenterology, Heraklion, Greece

P810: Serious pulmonary infections in patients with inflammatory bowel disease on treatment with anti-TNFECCO '18 Vienna
Year: 2018
Authors:

A. Algaba1*, I. Guerra1, A. Guardiola1, D. Bonillo1, A. Granja1, P. Bernal1, M.d.M. Aller1, B. Hernández2, C. Aulló3, F. Bermejo1

1Hospital Universitario de Fuenlabrada, Gastroenterology, Fuenlabrada, Spain, 2Hospital Universitario de Fuenlabrada, Pharmacy, Fuenlabrada, Spain, 3Hospital Universitario de Fuenlabrada, Radiology, Fuenlabrada, Spain

P811: Centre volume bias for restorative surgery after ulcerative colitis colectomy in England and SwedenECCO '18 Vienna
Year: 2018
Authors:

G. Worley1,2*, C. Nordenvall3,4, A. Askari1,2, T. Pinkney5, E. Burns1,2, A. Akbar1,6, O. Olén7,8, A. Ekbom7, M. Bottai9, P. Myrelid10,11, O. Faiz1,6

1Imperial College London, Department of Surgery and Cancer, London, UK, 2St Mark's Hospital and Academic Institute, Surgical Epidemiology Trials and Outcome Centre, London, UK, 3Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden, 4Karolinska University Hospital, Center for Digestive Disease, Division of Coloproctology, Stockholm, Sweden, 5University Hospitals Birmingham, Academic Department of Surgery, Birmingham, UK, 6St Mark's Hospital and Academic Institute, London, UK, 7Karolinska Institutet, Clinical Epidemiology Unit, Department of Medicine, Stockholm, Sweden, 8Karolinska Institutet, Sachs’ Children and Youth Hospital, Stockholm South General Hospital, and Department of Clinical Science and Education Södersjukhuset, Stockholm, Sweden, 9Karolinska Institutet, Unit of Biostatistics, Institute of Environmental Medicine, Stockholm, Sweden, 10Linköping University, Division of Surgery, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping, Sweden, 11County Council of Östergötland, Department of Surgery, Linköping, Sweden

P812: Natural disease course of inflammatory bowel disease unclassified in a prospective European population-based inception cohort—the Epi-IBD cohortECCO '18 Vienna
Year: 2018
Authors:

J. Burisch1*, P. Ellul2, N. Arebi3, I. Kaimakliotis4, R. D'Inca5, V. Andersen6,7, E. Belousova8, V. Hernandez9, Z. Vegh10, S. Turcan11, F. Magro12,13,14, L. Kupcinskas15, J. Halfvarson16, P.L. Lakatos10, D. Duricova17, L. Kievit18, A. Goldis19, J.F. Dahlerup20, P. Oksanen21, S. Čuković-Čavka22, M. Fumery23, S. Odes24, K.R. Nielsen25, D. Valpiani26, N. Pedersen27, M. Giannotta28, R. Salupere29, K.H. Katsanos30, E. Langholz31, P. Munkholm1, Epi-IBD study group

1North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark, 2Mater Dei Hospital, Division of Gastroenterology, L-Imsida, Malta, 3St Mark's Hospital, Gastroenterology, London, UK, 4Nicosia Private practice, Nicosia Private practice, Nicosia, Cyprus, 5Azienda Ospedaliera di Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy, 6Viborg Regional Hospital, Medical Department, Viborg, Denmark, 7Hospital of Southern Jutland, Medical Department, Aabenraa, Denmark, 8Moscow Regional Research Clinical Institute, Department of Gastroenterology, Moscow, Russian Federation, 9Complexo Hospitalario Universitario de Vigo, Gastroenterology Department, Vigo, Spain, 10Semmelweis University, 1st Department of Medicine, Budapest, Hungary, 11State University of Medicine and Pharmacy of the Republic of Moldova, Department of Gastroenterology, Chisinau, Moldova, Republic of, 12University of Porto, Institute for molecular and cell biology, Porto, Portugal, 13Hospital de São João, Department of Gastroenterology, Porto, Portugal, 14Oporto Medical School, Institute of Pharmacology and Therapeutics, Porto, Portugal, 15Lithuanian University of Health Sciences, Institute for Digestive Research, Kaunas, Lithuania, 16Faculty of Medicine and Health, Örebro University, Department of Gastronterology, Örebro, Sweden, 17Charles University, IBD Center ISCARE, Prague, Czech Republic, 18Herning Central Hospital, Department of medicine, Herning, Denmark, 19University of Medicine ‘Victor Babes’, Clinic of Gastroenterology, Timisoara, Romania, 20Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark, 21Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland, 22University Hospital Center Zagreb, University of Zagreb School of Medicine, Division of Gastroenterology and Hepatology, Zagreb, Croatia, 23Amiens University and Hospital, Epimad Registry, Gastroenterology Unit, Amiens, France, 24Soroka Medical Center and Ben Gurion University of the Negev, Department of Gastroenterology and Hepatology, Beer Sheva, Israel, 25The National Hospital of the Faroe Islands, Medical department, Tórshavn, Faroe Islands, 26Department of Gastroenterology and Digestive Endoscopy, Morgagni Hospital, Forli, Italy, 27Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark, 28AOU Careggi Regional Referral Center for Inflammatory Bowel Disease, Gastroenterology Department, Florence, Italy, 29Tartu University Hospital, Division of Endocrinology and Gastroenterology, Tartu, Estonia, 30University Hospital, Ioannina, 1st Division of Internal Medicine and Hepato-Gastroenterology Unit, Ioannina, Greece, 31Gentofte Hospital, Department of Medical Gastroenterology, Copenhagen, Denmark

P813: Occurrence, disease course and prognosis of perianal Crohn’s disease in a Danish population-based inception cohort—a 10-year follow-up studyECCO '18 Vienna
Year: 2018
Authors:

M. Zhao*, B. Lo, M. Vester-Andersen, I. Vind, F. Bendtsen, J. Burisch

Gastrounit, Hvidovre Hospital, Gastroenterology, Copenhagen, Denmark

P814: Latent cytomegalovirus infection does not influence disease course in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

K. van der Sloot1,2*, M. Voskuil1,3, R. Weersma1, M. Visschedijk1, N. Festen1,3, H. van Dullemen1, C. van Leer - Buter4, B. Alizadeh2, G. Dijkstra1

1University Medical Center Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands, 2University Medical Center Groningen, Epidemiology, Groningen, The Netherlands, 3University Medical Center Groningen, Genetics, Groningen, The Netherlands, 4University Medical Center Groningen, Medical Microbiology, Groningen, The Netherlands

P815: How to measure environmental exposures (the exposome) in inflammatory bowel disease?ECCO '18 Vienna
Year: 2018
Authors:

K. van der Sloot1,2*, B. Alizadeh2, G. Dijkstra1

1University Medical Center Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands, 2University Medical Center Groningen, Epidemiology, Groningen, The Netherlands

P816: IBSEN III—a new population-based inception cohort from South-Eastern NorwayECCO '18 Vienna
Year: 2018
Authors:

V.A. Kristensen1*, R. Opheim1,2, P. Ricanek3, G. Huppertz-Hauss4, G. Perminow5, T.E. Detlie6, K. Skram5, S. Vatn3, C. Olbjørn6, J. Rove6, R. Stray-Pedersen7, T.R. Ahmad8, A. Pedersen9, E. Skogestad10, H.K. Holm10, C.M. Ystrøm11, B. Aballi12, R. Torp13, O. Hovde14,15, S.O. Frigstad16, F.A. Halvorsen17, F. Vikskjold17, A. Sagosen18, M.B. Bengtson19, T.B. Aabrekk19, S. Andersen19, H. Yassin20, S. Dahler21, M. Henriksen22, K. Størdal23,24, E. Løvlund23, A. Hasund25, O. Høie26, K. Schmidt27, J. Pallenschatt28, M.L. Høivik1

1Oslo University Hospital, Department of Gastroenterology, Oslo, Norway, 2University of Oslo, Department of Nursing Science, Oslo, Norway, 3Akershus University Hospital, Department of Gastroenterology, Nordbyhagen, Norway, 4Telemark Hospital Trust, Skien, Skien, Norway, 5Oslo University Hospital, Department of Pediatrics, Oslo, Norway, 6Akershus University Hospital, Department of Pediatrics, Nordbyhagen, Norway, 7Diakonhjemmet Hospital, Department of Gastroenterology, Oslo, Norway, 8Lovisenberg Diaconal Hospital, Department of Medicine, Oslo, Norway, 9Innlandet Hospital Trust Kongsvinger, Kongsvinger, Norway, 10Innlandet Hospital Trust Lillehammer, Pediatric Department, Lillehammer, Norway, 11Innlandet Hospital Trust Elverum, Department of Medicine, Elverum, Norway, 12Innlandet Hospital Trust Elverum, Department of Pediatrics, Elverum, Norway, 13Sykehuset Innlandet Hamar, Department of Medicine, Hamar, Norway, 14Innlandet Hospital Trust Gjøvik, Department of Medicine, Gjøvik, Norway, 15University of Oslo, Oslo, Norway, 16Vestre Viken Hospital Trust Bærum, Department of Gastroenterology, Bærum, Norway, 17Vestre Viken Hospital Trust Drammen, Department of Pediatric and Adolescent Medicine, Drammen, Norway, 18Vestre Viken Hospital Trust Kongsberg, Department of Medicine, Kongsberg, Norway, 19Vestfold Hospital Trust, Tonsberg, Department of Pediatrics, Tonsberg, Norway, 20Telemark Hospital Trust Skien, Department of Pediatrics, Skien, Norway, 21Telemark Hospital Trust Notodden, Department of Medicine, Notodden, Norway, 22Østfold Hospital Trust, Department of Gastroenterology, Grålum, Norway, 23Østfold Hospital Trust, Department of Pediatrics, Grålum, Norway, 24Institute of Public Health, Oslo, Norway, 25Sørlandet Hospital Kristiansand, Department of Gastroenterology, Kristiansand, Norway, 26Sørlandet Hospital Arendal, Department of Gastroenterology, Arendal, Norway, 27Sørlandet Hospital Arendal, Department of Pediatrics, Arendal, Norway, 28Sørlandet Hospital Flekkefjord, Department of Medicine, Flekkefjord, Norway

P817: Live-vaccines and lactation in newborn exposed in utero to anti-TNF: A multi-centre French experience in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

S. Bendaoud1*, S. Nahon2, J.-M. Gornet3, B. Pariente4, L. Beaugerie5, V. Abitbol6, L. Peyrin-Biroulet7, A. Buisson8, X. Hebuterne9, R. Altwegg10, M. Amil11, I. Rosa12, F. Heluwaert13, L. Plastaras14, M. Antony15, A. Boureille16, Y. Bouhnik17, V. Quentin18, A. Aubourg19, M. Boualit20, K. Bideau21, E. Cuillerier22, C. Locher23

1APHP, Paris, France, 2Hopital Montfermeil, Montfermeil, France, 3Hopital Saint Louis, Paris, France, 4Hopital de Lille, Lille, France, 5Hopital Saint Antoine, Paris, France, 6Hopital de Cochin, Paris, France, 7Hopital de Nancy, Nancy, France, 8Hopital de Clermont Ferrand, Clermont-Ferrand, France, 9Hopital de Nice, Nice, France, 10Hopital Montpellier, Montpellier, France, 11Hopital de Vendée, Vendée, France, 12CHIC, Créteil, France, 13Centre Hospitalier Annecy, Annecy, France, 14Hopital de Colmar, Colmar, France, 15Orange, Orange, France, 16Hopital de Nantes, Nantes, France, 17Hopital de Beaujon, Clichy, France, 18Hopital saint brieuc, Saint brieuc, France, 19Hopital de tours, Tours, France, 20CH valenciennes, Valenciennes, France, 21hopital Quimper, Quimper, France, 22Hopital Dreux, Dreux, France, 23Hopital de Meaux, Meaux, France

P818: Prevalence and risk factors of comorbid immune-mediated diseases in patients with inflammatory bowel disease: A nationwide population-based study in South KoreaECCO '18 Vienna
Year: 2018
Authors:

S.-W. Park1*, T.J. Kim1, E.R. Kim1, S.N. Hong1, D.K. Chang1, M. Yang2, M.-H. Shin3, Y.-H. Kim1

1Samsung Medical Center, Sungkyunkwan University School of Medicine, Department of medicine, Seoul, South Korea, 2Samsung Medical Center, Sungkyunkwan University School of Medicine, Statistics and Data Center, Seoul, South Korea, 3Samsung Medical Center, Sungkyunkwan University School of Medicine, Department of Social and Preventive Medicine, Seoul, South Korea

P819: Smoking in UC is associated with decreased thiopurine use but not steroid dependency or colectomyECCO '18 Vienna
Year: 2018
Authors:

J. Blackwell1*, C. Alexakis1, E. Cecil2, S. Saxena2, R. Pollok1

1St George's Healthcare NHS Trust, Gastroenterology, London, UK, 2Imperial College London, School of Public Health, London, UK

P820: The interleukin-6 receptor as a target for prevention of Crohn’s disease and ulcerative colitis; a Mendelian randomisation studyECCO '18 Vienna
Year: 2018
Authors:

C.A. Parisinos1*, S. Serghiou2, M. Katsoulis1, R.S. Patel1,3, H. Hemingway1, A.D. Hingorani1,3

1UCL, Institute of Health Informatics, London, UK, 2Stanford University, Stanford, USA, 3UCL, Institute of Cardiovascular Sciences, London, UK

P821: Incidence of paediatric stricturing duodenal Crohn’s disease in South-East Scotland: A 12-year population-based cohort studyECCO '18 Vienna
Year: 2018
Authors:

C. Burgess1*, P. Gillett2, D. Mitchell2, P. Hammond3, P. Henderson1,2, D. Wilson1,2

1University of Edinburgh, Department of Child Life and Health, Edinburgh, UK, 2Royal Hospital For Sick Children, Department of Gastroenterology and Nutrition, Edinburgh, UK, 3Royal Hospital For Sick Children, Department of Paediatric Surgery, Edinburgh, UK

P822: Impact of extra-intestinal manifestations at diagnosis on disease outcome in paediatric- and elderly-onset Crohn´s Disease: A French population-based studyECCO '18 Vienna
Year: 2018
Authors:

D. Duricová1*, H. Sarter2,3, G. Savoye4, A. Leroyer2, B. Pariente5, L. Armengol-Debeir4, G. Bouguen6, D. Ley3,7, D. Turck3,7, C. Templier8, S. Buche8, L. Peyrin-Biroulet9, C. Gower-Rousseau2,3, M. Fumery10

1IBD clinical and research centre, Iscare, Prague, Czech Republic, 2Public Health, Epidemiology and Economic Health, Registre Epimad, Maison Régionale de la Recherche Clinique, Lille University and Hospital, Lille, France, 3Lille Inflammation Research International Center LIRIC - UMR 995 Inserm Lille 2 University, CHRU de Lille, Lille, France, 4Gastroenterology Unit, Epimad Registry, Hôpital Charles Nicolle, Rouen University Hospital, Rouen, France, 5Gastroenterology Unit, Hôpital Huriez, Lille University Hospital, Lille, France, 6Gastroenterology Unit, Rennes University Hospital, Rennes, France, 7Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Lille University Jeanne de Flandre Children’s Hospital, University of Lille, Lille, France, 8Dermatology Unit, Hôpital Huriez, Lille University Hospital, Lille, France, 9Gastroenterology Unit, Inserm U954, Nancy University and Hospital, Nancy, France, 10Gastroenterology Unit, Epimad Registry, CHU Amiens Sud, l, Amiens University Hospital, Amiens, France

P823: Effects of smoking cessation in IBD: Insights from the Swiss IBD Cohort study (SIBCS)ECCO '18 Vienna
Year: 2018
Authors:

M. Martinho-Grueber1*, L. Biedermann2, S. Vavricka3, A. Schöpfer4, C. Clair Willi5, N. Fournier6, M. Allez7, A.J. Macpherson8, P. Juillerat9

1Inselspital, Bern, Department of Gastroenterology, Bern, Switzerland, 2Universitätsspital, Gastroenterology, Zürich, Switzerland, 3Stadtspital Triemli, Gastroenterology, Zürich, Switzerland, 4CHUV, Gastroenterology, Lausanne, Switzerland, 5CHUV, PMU, Lausanne, Switzerland, 6CHUV, Statistics, Lausanne, Switzerland, 7Hôpital Saint-Louis, Gastroenterology, Lausanne, France, 8Inselpital, Gastroenterology, Bern, Switzerland, 9Inselspital, Gastroenterology, Bern, Switzerland

P824: Increased risk of anxiety and depression in patients with inflammatory bowel disease: A nationwide population-based study in KoreaECCO '18 Vienna
Year: 2018
Authors:

G. Choi1, K. Han2, J. Chun1, C. Lee1, J.P. Im1, J.-S. Kim1*

1Seoul National University College of Medicine, Department of Internal Medicine, Seoul, South Korea, 2College of Medicine, The Catholic University of Korea, Dept of Medical Statistics, Seoul, South Korea

P825: The “other burden” of ulcerative colitis: Impact on social and professional life described by Spanish patientsECCO '18 Vienna
Year: 2018
Authors:

A. López-Sanromán1*, F. Argüelles-Arias2, X. Calvet3,4, L. Cea-Calvo5, B. Juliá5, C. Romero5, D. Carpio6,7

1Gastroenterology Section, Hospital Ramón y Cajal, Madrid, Spain, 2Hospital Universitario Virgen Macarena, Sevilla, Spain, 3Unitat de Malalties Digestives. Corporació Sanitaria Universitària Parc Taulí, Sabadell, Spain, 4Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain, 5Merck Sharp & Dohme, Spain, Medical Affairs, Madrid, Spain, 6Servicio de Gastroenterología Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain, 7Instituto de Investigación Biomedica (IBI). SERGAS, Pontevedra, Spain

P826: Lower socioeconomic status is associated with disability in inflammatory bowel disease patientsECCO '18 Vienna
Year: 2018
Authors:

M. Agrawal1,2*, S. Cohen-Mekelburg3, M. Kayal4, J. Axelrad5, J. Galati3, K. Kamal4, B. Tricomi1,2, A. Faye5, E. Scherl3, G. Lawlor5, D. Lukin1,2, J.-F. Colombel4, R. Ungaro4

1Montefiore Medical Center, Bronx, USA, 2Albert Einstein College of Medicine, Bronx, USA, 3Weill Cornell Medical College, New York, USA, 4Icahn School of Medicine at Mount Sinai, New York, USA, 5Columbia University Medical Center, New York, USA

P827: Prevalence of viral hepatitis in patients with IBD: A multi-centre and population-based studyECCO '18 Vienna
Year: 2018
Authors:

E. Badia1*, J. Barrio2, L. Fernández-Salazar3, A. Fuentes4, G. Hontoria1, B. Sicilia1, on behalf of Castilla y León Inflammatory Bowel Disease Group (GEICYL)

1University Hospital of Burgos, Department of Gastroenterology, Burgos, Spain, 2University Hospital Rio Hortega, Department of Gastroenterology, Valladolid, Spain, 3University Hospital Clinic Valladolid, Department of Gastroenterology, Valladolid, Spain, 4Hospital Virgen de la Concha, Department of Gastroenterology, Zamora, Spain

P828: Frequency and characteristics of perianal fistulas in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

A. Balint1*, K. Farkas1, Z. Szepes1, T. Molnár1, T. Nyári2, F. Nagy1

1University of Szeged, 1st Department of Medicine, Szeged, Hungary, 2University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary